Evidence map›Paper›PMID 32265562›Full record

ArticleNature biotechnology2020

Efficient production of male Wolbachia-infected Aedes aegypti mosquitoes enables large-scale suppression of wild populations.

Jacob E Crawford, David W Clarke, Victor Criswell, Mark Desnoyer, Devon Cornel, Brittany Deegan, Kyle Gong, Kaycie C Hopkins, Paul Howell, Justin S Hyde and 44 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 204 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
204citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

204 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. In Saccharomyces cerevisiae ΔRIB1 and ΔRIB4 mutants, riboflavin auxotrophy is reverted by Wolbachia (wStr) infection.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  10. Article
  11. Research Trends and Collaborative Patterns inInternational journal of environmental research and public health · 2026
    Article
  12. EliminatingInsects · 2026
    Article
  13. Article
  14. Article
  15. Temperature-sensitive cytoplasmic incompatibility across divergentbioRxiv : the preprint server for biology · 2026
    Article
  16. The microbiota impacts life history traits and mating success in malebioRxiv : the preprint server for biology · 2026
    Article
  17. Review
  18. Article
  19. ModellingJournal of pest science · 2026
    Article
  20. The inhibition mechanism ofFrontiers in microbiology · 2026
    Review

144 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

54 authors.

Jacob E CrawfordVerily Life Sciences, South San Francisco, CA, USA. jacobcrawford@verily.com.ORCID http://orcid.org/0000-0002-6745-9145
David W ClarkeVerily Life Sciences, South San Francisco, CA, USA.
Victor CriswellVerily Life Sciences, South San Francisco, CA, USA.
Mark DesnoyerVerily Life Sciences, South San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-6266-2235
Devon CornelConsolidated Mosquito Abatement District, Parlier, CA, USA.
Brittany DeeganConsolidated Mosquito Abatement District, Parlier, CA, USA.
Kyle GongVerily Life Sciences, South San Francisco, CA, USA.
Kaycie C HopkinsVerily Life Sciences, South San Francisco, CA, USA.
Paul HowellVerily Life Sciences, South San Francisco, CA, USA.
Justin S HydeVerily Life Sciences, South San Francisco, CA, USA.
Josh LivniVerily Life Sciences, South San Francisco, CA, USA.
Charlie BehlingVerily Life Sciences, South San Francisco, CA, USA.
Renzo BenzaVerily Life Sciences, South San Francisco, CA, USA.
Willa ChenVerily Life Sciences, South San Francisco, CA, USA.
Karen L DobsonMosquitoMate Inc., Lexington, KY, USA.
Craig EldershawVerily Life Sciences, South San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-6855-3272
Daniel GreeleyVerily Life Sciences, South San Francisco, CA, USA.
Yi HanVerily Life Sciences, South San Francisco, CA, USA.
Bridgette HughesVerily Life Sciences, South San Francisco, CA, USA.
Evdoxia KakaniVerily Life Sciences, South San Francisco, CA, USA.
Joe KarbowskiVerily Life Sciences, South San Francisco, CA, USA.
Angus KitchellVerily Life Sciences, South San Francisco, CA, USA.
Erika LeeVerily Life Sciences, South San Francisco, CA, USA.
Teresa LinVerily Life Sciences, South San Francisco, CA, USA.
Jianyi LiuVerily Life Sciences, South San Francisco, CA, USA.
Martin LozanoVerily Life Sciences, South San Francisco, CA, USA.
Warren MacDonaldVerily Life Sciences, South San Francisco, CA, USA.
James W MainsMosquitoMate Inc., Lexington, KY, USA.
Matty MetlitzVerily Life Sciences, South San Francisco, CA, USA.
Sara N MitchellVerily Life Sciences, South San Francisco, CA, USA.
David MooreVerily Life Sciences, South San Francisco, CA, USA.
Johanna R OhmVerily Life Sciences, South San Francisco, CA, USA.
Kathleen ParkesVerily Life Sciences, South San Francisco, CA, USA.
Alexandra PorshnikoffVerily Life Sciences, South San Francisco, CA, USA.
Chris RobuckVerily Life Sciences, South San Francisco, CA, USA.
Martin SheridanVerily Life Sciences, South San Francisco, CA, USA.
Robert SobeckiVerily Life Sciences, South San Francisco, CA, USA.
Peter SmithVerily Life Sciences, South San Francisco, CA, USA.
Jessica StevensonVerily Life Sciences, South San Francisco, CA, USA.
Jordan SullivanVerily Life Sciences, South San Francisco, CA, USA.
Brian WassonVerily Life Sciences, South San Francisco, CA, USA.
Allison M WeakleyVerily Life Sciences, South San Francisco, CA, USA.
Mark WilhelmVerily Life Sciences, South San Francisco, CA, USA.
Joshua WonVerily Life Sciences, South San Francisco, CA, USA.
Ari YasunagaVerily Life Sciences, South San Francisco, CA, USA.
William C ChanVerily Life Sciences, South San Francisco, CA, USA.
Jodi HolemanConsolidated Mosquito Abatement District, Parlier, CA, USA.
Nigel SnoadVerily Life Sciences, South San Francisco, CA, USA.
Linus UpsonVerily Life Sciences, South San Francisco, CA, USA.
Tiantian ZhaVerily Life Sciences, South San Francisco, CA, USA.
Stephen L DobsonMosquitoMate Inc., Lexington, KY, USA.
F Steven MulliganConsolidated Mosquito Abatement District, Parlier, CA, USA.
Peter MassaroVerily Life Sciences, South San Francisco, CA, USA.
Bradley J WhiteVerily Life Sciences, South San Francisco, CA, USA. bradwhite@verily.com.ORCID http://orcid.org/0000-0002-6444-4159

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The range of the mosquito Aedes aegypti continues to expand, putting more than two billion people at risk of arboviral infection. The sterile insect technique (SIT) has been used to successfully combat agricultural pests at large scale, but not mosquitoes, mainly because of challenges with consistent production and distribution of high-quality male mosquitoes. We describe automated processes to rear and release millions of competitive, sterile male Wolbachia-infected mosquitoes, and use of these males in a large-scale suppression trial in Fresno County, California. In 2018, we released 14.4 million males across three replicate neighborhoods encompassing 293 hectares. At peak mosquito season, the number of female mosquitoes was 95.5% lower (95% CI, 93.6-96.9) in release areas compared to non-release areas, with the most geographically isolated neighborhood reaching a 99% reduction. This work demonstrates the high efficacy of mosquito SIT in an area ninefold larger than in previous similar trials, supporting the potential of this approach in public health and nuisance-mosquito eradication programs.

Indexed as

AedesAnimal MigrationAnimalsCaliforniaFemaleLarvaMaleMosquito ControlMosquito VectorsPopulation DynamicsSex CharacteristicsWolbachia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.